Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-11334

Stähli, B E; Camici, G G; Tanner, F C (2009). Drug-eluting stent thrombosis. Therapeutic Advances in Cardiovascular Disease, 3(1):45-52.

[img]
Preview
Accepted Version
PDF
1MB

View at publisher

Abstract

Stent thrombosis is a rare complication following stent implantation; if it occurs, however, it is associated with a high morbidity and mortality. Despite reduced rates of restenosis, drug-eluting stents (DES) have not reduced the incidence of stent thrombosis as compared with bare-metal stents (BMS). Patient-, lesion-, and procedure-related factors as well as thrombogenicity of the stent itself are involved in the pathogenesis of stent thrombosis. Furthermore, early cessation of dual antiplatelet therapy correlates with an increased risk of stent thrombosis. This review focuses on clinical evidence and pathophysiological mechanisms of stent thrombosis with DES, particularly highlighting prothrombotic effects of the stent itself.

Citations

Altmetrics

Downloads

22 downloads since deposited on 13 Mar 2009
9 downloads since 12 months

Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > Center for Integrative Human Physiology
04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiology
04 Faculty of Medicine > Institute of Physiology
07 Faculty of Science > Institute of Physiology
DDC:570 Life sciences; biology
610 Medicine & health
Language:English
Date:February 2009
Deposited On:13 Mar 2009 08:25
Last Modified:18 Jul 2014 21:12
Publisher:Sage Publications
ISSN:1753-9447
Additional Information:Cardiovascular Research, Institute of Physiology, University of Zurich
Publisher DOI:10.1177/1753944708096280
PubMed ID:19124388

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page